tiprankstipranks
Trending News
More News >
Astellas Pharma Inc (JP:4503)
:4503
Japanese Market

Astellas Pharma (4503) Income Statement

Compare
3 Followers

Astellas Pharma Income Statement

Last quarter (Q4 2024), Astellas Pharma's total revenue was ¥459.29B, an increase of 10.78% from the same quarter last year. In Q4, Astellas Pharma's net income was ¥74.90B. See Astellas Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 1.91T¥ 1.60T¥ 1.52T¥ 1.30T¥ 1.25T
Gross Profit
¥ 1.43T¥ 1.31T¥ 1.23T¥ 1.04T¥ 1.00T
Operating Expenses
¥ 1.17T¥ 1.29T¥ 1.10T¥ 912.19B¥ 867.89B
Depreciation and Amortization
¥ 199.13B¥ 157.84B¥ 105.74B¥ 79.68B¥ 72.65B
EBITDA
¥ 248.30B¥ 195.34B¥ 240.46B¥ 241.03B¥ 219.83B
Operating Income
¥ 255.67B¥ 124.61B¥ 133.03B¥ 155.69B¥ 136.05B
Other Income/Expenses
¥ -224.18B¥ -99.64B¥ -668.00M¥ 1.20B¥ 8.79B
Pretax Income
¥ 31.50B¥ 24.97B¥ 132.36B¥ 156.89B¥ 145.32B
Net Income
¥ 50.75B¥ 17.05B¥ 98.71B¥ 124.09B¥ 120.59B
Per Share Metrics
Basic EPS
¥ 28.35¥ 9.50¥ 54.24¥ 67.08¥ 64.93
Diluted EPS
¥ 28.24¥ 9.47¥ 54.09¥ 67.05¥ 64.90
Weighted Average Shares Outstanding
1.79B 1.79B 1.82B 1.85B 1.86B
Weighted Average Shares Outstanding (Diluted)
1.80B 1.80B 1.83B 1.85B 1.86B
Currency in JPY

Astellas Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis